{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:18:18Z","timestamp":1793384298670,"version":"4.5.0"},"reference-count":96,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,2,28]]},"abstract":"<jats:sec id=\"ab-jrv230002-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Borderline personality disorder (BPD) affects approximately 0.7% to 2.7% of adults in the US. The disorder is associated with considerable social and vocational impairments and greater use of medical services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv230002-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>Borderline personality disorder is characterized by sudden shifts in identity, interpersonal relationships, and affect, as well as by impulsive behavior, periodic intense anger, feelings of emptiness, suicidal behavior, self-mutilation, transient, stress-related paranoid ideation, and severe dissociative symptoms (eg, experience of unreality of one\u2019s self or surroundings). Borderline personality disorder is typically diagnosed by a mental health specialist using semistructured interviews. Most people with BPD have coexisting mental disorders such as mood disorders (ie, major depression or bipolar disorder) (83%), anxiety disorders (85%), or substance use disorders (78%). The etiology of BPD is related to both genetic factors and adverse childhood experiences, such as sexual and physical abuse. Psychotherapy is the treatment of choice for BPD. Psychotherapy such as dialectical behavior therapy and psychodynamic therapy reduce symptom severity more than usual care, with medium effect sizes (standardized mean difference) between \u22120.60 and \u22120.65. There is no evidence that any psychoactive medication consistently improves core symptoms of BPD. For discrete and severe comorbid mental disorders, eg, major depression, pharmacotherapy such as the selective serotonin reuptake inhibitors escitalopram, sertraline, or fluoxetine may be prescribed. For short-term treatment of acute crisis in BPD, consisting of suicidal behavior or ideation, extreme anxiety, psychotic episodes, or other extreme behavior likely to endanger a patient or others, crisis management is required, which may include prescription of low-potency antipsychotics (eg, quetiapine) or off-label use of sedative antihistamines (eg, promethazine). These drugs are preferred over benzodiazepines such as diazepam or lorazepam.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-jrv230002-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Borderline personality disorder affects approximately 0.7% to 2.7% of adults and is associated with functional impairment and greater use of medical services. Psychotherapy with dialectical behavior therapy and psychodynamic therapy are first-line therapies for BPD, while psychoactive medications do not improve the primary symptoms of BPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2023.0589","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:01:49Z","timestamp":1677582109000},"page":"670","source":"Crossref","is-referenced-by-count":211,"title":["Borderline Personality Disorder"],"prefix":"10.1001","volume":"329","author":[{"given":"Falk","family":"Leichsenring","sequence":"first","affiliation":[{"name":"Department of Psychosomatics and Psychotherapy, University of Giessen, Giessen, Germany"},{"name":"Department of Psychosomatics and Psychotherapy, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Heim","sequence":"additional","affiliation":[{"name":"International Psychoanalytic University, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Leweke","sequence":"additional","affiliation":[{"name":"Department of Psychosomatics and Psychotherapy, University of Giessen, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Spitzer","sequence":"additional","affiliation":[{"name":"Department of Psychosomatics and Psychotherapy, University of Rostock, Rostock, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Steinert","sequence":"additional","affiliation":[{"name":"Department of Psychosomatics and Psychotherapy, University of Giessen, Giessen, Germany"},{"name":"International Psychoanalytic University, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto F.","family":"Kernberg","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College, Personality Disorders Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jrv230002r3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.copsyc.2017.09.001","article-title":"Personality disorders: community prevalence and socio-demographic correlates.","volume":"21","author":"Eaton","year":"2018","journal-title":"Curr Opin Psychol"},{"issue":"4","key":"jrv230002r4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.psc.2018.07.008","article-title":"Community and clinical epidemiology of borderline personality disorder.","volume":"41","author":"Ellison","year":"2018","journal-title":"Psychiatr Clin North Am"},{"key":"jrv230002r5","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722002197","article-title":"The hidden borderline patient: patients with borderline personality disorder who do not engage in recurrent suicidal or self-injurious behavior.","author":"Zimmerman","year":"2022","journal-title":"Psychol Med"},{"issue":"5","key":"jrv230002r6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1521\/pedi_2012_26_093","article-title":"Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning.","volume":"28","author":"Tomko","year":"2014","journal-title":"J Pers Disord"},{"key":"jrv230002r7","doi-asserted-by":"publisher","first-page":"18029","DOI":"10.1038\/nrdp.2018.29","article-title":"Borderline personality disorder.","volume":"4","author":"Gunderson","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"jrv230002r8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1521\/pedi_2018_32_344","article-title":"Low vocational outcome among people diagnosed with borderline personality disorder during first admission to mental health services in Denmark: a nationwide 9-year register-based study.","volume":"33","author":"Hastrup","year":"2019","journal-title":"J Pers Disord"},{"issue":"23-24","key":"jrv230002r9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3238\/arztebl.2019.0405","article-title":"Mortality and medical comorbidity in the severely mentally ill.","volume":"116","author":"Schneider","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"jrv230002r10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00406-021-01332-1","article-title":"The societal cost of treatment-seeking patients with borderline personality disorder in Germany.","volume":"272","author":"Wagner","year":"2022","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"jrv230002r11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eurpsy.2018.10.010","article-title":"Long-term clinical and functional course of borderline personality disorder: a meta-analysis of prospective studies.","volume":"56","author":"\u00c1lvarez-Tom\u00e1s","year":"2019","journal-title":"Eur Psychiatry"},{"issue":"1","key":"jrv230002r12","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.18m12436","article-title":"Deaths by suicide and other causes among patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up.","volume":"80","author":"Temes","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"jrv230002r13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1521\/pedi.19.1.19.62178","article-title":"Psychosocial functioning of borderline patients and axis II comparison subjects followed prospectively for six years.","volume":"19","author":"Zanarini","year":"2005","journal-title":"J Pers Disord"},{"issue":"3","key":"jrv230002r14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1017\/S003329170400354X","article-title":"Stability of functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder over two years.","volume":"35","author":"Skodol","year":"2005","journal-title":"Psychol Med"},{"issue":"3","key":"jrv230002r15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1521\/pedi.18.3.226.35445","article-title":"Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention.","volume":"18","author":"Black","year":"2004","journal-title":"J Pers Disord"},{"issue":"5","key":"jrv230002r16","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41380-022-01503-z","article-title":"Borderline personality disorder: associations with psychiatric disorders, somatic illnesses, trauma, and adverse behaviors.","volume":"27","author":"Tate","year":"2022","journal-title":"Mol Psychiatry"},{"key":"jrv230002r17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1521\/pedi.1989.3.1.10","article-title":"The Revised Diagnostic Interview for Borderlines: discriminating BPD from other Axis II disorders.","volume":"3","author":"Zanarini","year":"1989","journal-title":"J Pers Disord"},{"issue":"6","key":"jrv230002r19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1192\/bjp.2018.202","article-title":"Prevalence of personality disorders in the general adult population in Western countries: systematic review and meta-analysis.","volume":"213","author":"Volkert","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"3","key":"jrv230002r20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","article-title":"Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States.","volume":"21","author":"Kessler","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"issue":"2","key":"jrv230002r21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/ije\/dyu038","article-title":"The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.","volume":"43","author":"Steel","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"12","key":"jrv230002r22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11920-013-0422-z","article-title":"Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.","volume":"15","author":"Zimmerman","year":"2013","journal-title":"Curr Psychiatry Rep"},{"issue":"16","key":"jrv230002r23","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jpsychires.2010.04.016","article-title":"Comorbidity of borderline personality disorder and posttraumatic stress disorder in the US population.","volume":"44","author":"Pagura","year":"2010","journal-title":"J Psychiatr Res"},{"issue":"4","key":"jrv230002r24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1017\/S003329171100153X","article-title":"The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).","volume":"42","author":"Bernardi","year":"2012","journal-title":"Psychol Med"},{"key":"jrv230002r25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.copsyc.2020.09.010","article-title":"Borderline personality disorder: course and outcomes across the lifespan.","volume":"37","author":"Winsper","year":"2021","journal-title":"Curr Opin Psychol"},{"issue":"12","key":"jrv230002r26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/0004867416640100","article-title":"Missed diagnosis: the emerging crisis of borderline personality disorder in older people.","volume":"50","author":"Beatson","year":"2016","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"jrv230002r27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/YCO.0000000000000764","article-title":"Borderline personality disorder and ageing: myths and realities.","volume":"35","author":"D\u2019Agostino","year":"2022","journal-title":"Curr Opin Psychiatry"},{"issue":"3-4","key":"jrv230002r30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000507589","article-title":"International assessment of DSM-5 and ICD-11 personality disorder traits: toward a common nosology in DSM-5.1.","volume":"53","author":"Bach","year":"2020","journal-title":"Psychopathology"},{"issue":"1","key":"jrv230002r31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12888-018-1908-3","article-title":"Application of the ICD-11 classification of personality disorders.","volume":"18","author":"Bach","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"12","key":"jrv230002r32","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0006-3223(02)01324-0","article-title":"The borderline diagnosis I: psychopathology, comorbidity, and personality structure.","volume":"51","author":"Skodol","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"6","key":"jrv230002r33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/archpsyc.1981.01780310093010","article-title":"Borderline personality and the Rorschach test.","volume":"38","author":"Singer","year":"1981","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"jrv230002r34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000284633","article-title":"Discriminating borderline from neurotic patients: a study with the Holtzman inkblot technique.","volume":"23","author":"Leichsenring","year":"1990","journal-title":"Psychopathology"},{"issue":"1","key":"jrv230002r35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000284695","article-title":"Primary process thinking, primitive defensive operations and object relationships in borderline and neurotic patients.","volume":"24","author":"Leichsenring","year":"1991","journal-title":"Psychopathology"},{"issue":"3","key":"jrv230002r36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1207\/S15327752JPA7303_9","article-title":"Use of the TAT in the assessment of DSM-IV cluster B personality disorders.","volume":"73","author":"Ackerman","year":"1999","journal-title":"J Pers Assess"},{"issue":"11","key":"jrv230002r37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1017\/S0033291708002924","article-title":"Dimensional representations of DSM-IV cluster B personality disorders in a population-based sample of Norwegian twins: a multivariate study.","volume":"38","author":"Torgersen","year":"2008","journal-title":"Psychol Med"},{"issue":"1","key":"jrv230002r38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12888-017-1383-2","article-title":"Borderline personality disorder and childhood trauma: exploring the affected biological systems and mechanisms.","volume":"17","author":"Cattane","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"4","key":"jrv230002r39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.psc.2018.07.012","article-title":"The neurobiology of borderline personality disorder.","volume":"41","author":"Perez-Rodriguez","year":"2018","journal-title":"Psychiatr Clin North Am"},{"key":"jrv230002r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109782","article-title":"Pathoetiology and pathophysiology of borderline personality: role of prenatal factors, gut microbiome, mu- and kappa-opioid receptors in amygdala-PFC interactions.","volume":"98","author":"Anderson","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"jrv230002r41","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1017\/S0033291710001297","article-title":"Life events and borderline personality features: the influence of gene-environment interaction and gene-environment correlation.","volume":"41","author":"Distel","year":"2011","journal-title":"Psychol Med"},{"issue":"1","key":"jrv230002r42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1017\/S0954579411000812","article-title":"Etiological features of borderline personality related characteristics in a birth cohort of 12-year-old children.","volume":"24","author":"Belsky","year":"2012","journal-title":"Dev Psychopathol"},{"issue":"3","key":"jrv230002r43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41380-019-0442-0","article-title":"Familial risk and heritability of diagnosed borderline personality disorder: a register study of the Swedish population.","volume":"26","author":"Skoglund","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"6","key":"jrv230002r44","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.115","article-title":"Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.","volume":"7","author":"Witt","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"4","key":"jrv230002r45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1037\/per0000186","article-title":"A systematic review of risk factors prospectively associated with borderline personality disorder: taking stock and moving forward.","volume":"7","author":"Stepp","year":"2016","journal-title":"Personal Disord"},{"issue":"1","key":"jrv230002r46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.v141.1","article-title":"Childhood adversity and borderline personality disorder: a meta-analysis.","volume":"141","author":"Porter","year":"2020","journal-title":"Acta Psychiatr Scand"},{"key":"jrv230002r47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.psyneuen.2018.12.009","article-title":"Systematic review and meta-analysis of basal cortisol levels in borderline personality disorder compared to non-psychiatric controls.","volume":"102","author":"Thomas","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"jrv230002r48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neubiorev.2018.11.008","article-title":"Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: a meta-analysis.","volume":"96","author":"Drews","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"jrv230002r49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neubiorev.2020.04.023","article-title":"Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis.","volume":"114","author":"Peled-Avron","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"jrv230002r50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bpsc.2018.11.004","article-title":"Neural correlates of affective disturbances: a comparative meta-analysis of negative affect processing in borderline personality disorder, major depressive disorder, and posttraumatic stress disorder.","volume":"4","author":"Schulze","year":"2019","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"1","key":"jrv230002r51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41398-021-01446-z","article-title":"Parsing variability in borderline personality disorder: a meta-analysis of neuroimaging studies.","volume":"11","author":"Degasperi","year":"2021","journal-title":"Transl Psychiatry"},{"key":"jrv230002r52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.copsyc.2020.12.002","article-title":"Emotion dysregulation in borderline personality disorder: a fronto-limbic imbalance?","volume":"37","author":"Sicorello","year":"2021","journal-title":"Curr Opin Psychol"},{"key":"jrv230002r53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/clinpsy.2019.15.issue-1","article-title":"The development of the ICD-11 classification of personality disorders: an amalgam of science, pragmatism, and politics.","volume":"15","author":"Tyrer","year":"2019","journal-title":"Annu Rev Clin Psychol"},{"issue":"5","key":"jrv230002r54","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.mcna.2014.06.005","article-title":"Borderline personality disorder in the primary care setting.","volume":"98","author":"Dubovsky","year":"2014","journal-title":"Med Clin North Am"},{"issue":"6","key":"jrv230002r55","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/practneurol-2019-002292","article-title":"Borderline personality disorder: an update for neurologists.","volume":"19","author":"Hall","year":"2019","journal-title":"Pract Neurol"},{"issue":"6","key":"jrv230002r57","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1521\/pedi_2013_27_106","article-title":"Factors related to dropout from treatment in two outpatient treatments for borderline personality disorder.","volume":"27","author":"Wnuk","year":"2013","journal-title":"J Pers Disord"},{"key":"jrv230002r58","doi-asserted-by":"publisher","DOI":"10.1080\/09638237.2019.1581337","article-title":"Stigma perpetuation at the interface of mental health care: a review to compare patient and clinician perspectives of stigma and borderline personality disorder.","author":"Ring","year":"2019","journal-title":"J Ment Health"},{"issue":"1","key":"jrv230002r59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1207\/S15327752JPA730104","article-title":"Development and first results of the Borderline Personality Inventory: a self-report instrument for assessing borderline personality organization.","volume":"73","author":"Leichsenring","year":"1999","journal-title":"J Pers Assess"},{"issue":"5","key":"jrv230002r60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012955.pub2","article-title":"Psychological therapies for people with borderline personality disorder.","volume":"5","author":"Storeb\u00f8","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"jrv230002r63","first-page":"288","article-title":"Crisis intervention of borderline personality disorder.","volume":"12","author":"Giernalczyk","year":"2007","journal-title":"Psychotherapie"},{"issue":"3","key":"jrv230002r64","first-page":"261","article-title":"Dialectical behavior therapy for borderline personality disorder: theory and method.","volume":"51","author":"Linehan","year":"1987","journal-title":"Bull Menninger Clin"},{"issue":"4","key":"jrv230002r66","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000284718","article-title":"Discriminating schizophrenics from borderline patients: study with the Holtzman inkblot technique.","volume":"24","author":"Leichsenring","year":"1991","journal-title":"Psychopathology"},{"issue":"2","key":"jrv230002r67","first-page":"156","article-title":"Borderline personality disorder.","volume":"105","author":"Mendez-Miller","year":"2022","journal-title":"Am Fam Physician"},{"issue":"2","key":"jrv230002r68","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1521\/pedi_2018_32_340","article-title":"A randomized controlled trial of group psychoeducation for carers of persons with borderline personality disorder.","volume":"33","author":"Grenyer","year":"2019","journal-title":"J Pers Disord"},{"issue":"5","key":"jrv230002r69","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1176\/appi.ajp.2015.15070885","article-title":"The emergence of a generalist model to meet public health needs for patients with borderline personality disorder.","volume":"173","author":"Gunderson","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"6","key":"jrv230002r70","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1176\/ajp.2007.164.6.922","article-title":"Evaluating three treatments for borderline personality disorder: a multiwave study.","volume":"164","author":"Clarkin","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"12","key":"jrv230002r71","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1176\/appi.ajp.2009.09010039","article-title":"A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder.","volume":"166","author":"McMain","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"12","key":"jrv230002r72","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1176\/appi.ajp.2009.09040539","article-title":"Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder.","volume":"166","author":"Bateman","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"10","key":"jrv230002r73","first-page":"1","article-title":"Practice guideline for the treatment of patients with borderline personality disorder.","volume":"158","author":"American Psychiatric Association","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"10","key":"jrv230002r74","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-021-00855-4","article-title":"Pharmacological treatments for borderline personality disorder: a systematic review and meta-analysis.","volume":"35","author":"Gartlehner","year":"2021","journal-title":"CNS Drugs"},{"issue":"10310","key":"jrv230002r75","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/S0140-6736(21)00476-1","article-title":"Borderline personality disorder.","volume":"398","author":"Bohus","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"jrv230002r76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012956.pub2","article-title":"Pharmacological interventions for people with borderline personality disorder.","volume":"11","author":"Stoffers-Winterling","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"jrv230002r77","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jad.2021.03.088","article-title":"Effects of pharmacological treatments on emotional tasks in borderline personality disorder: a review of functional magnetic resonance imaging studies.","volume":"288","author":"Cattarinussi","year":"2021","journal-title":"J Affect Disord"},{"key":"jrv230002r78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neubiorev.2018.09.001","article-title":"Biomarker correlates of psychotherapy outcomes in borderline personality disorder: a systematic review.","volume":"94","author":"Marceau","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"jrv230002r79","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1521\/pedi.2010.24.4.412","article-title":"Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders.","volume":"24","author":"Trull","year":"2010","journal-title":"J Pers Disord"},{"issue":"6","key":"jrv230002r80","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0269881120959615","article-title":"Beyond the \u201cpurple drank\u201d: study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.","volume":"35","author":"Chiappini","year":"2021","journal-title":"J Psychopharmacol"},{"issue":"9969","key":"jrv230002r82","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(14)61394-5","article-title":"Treatment of personality disorder.","volume":"385","author":"Bateman","year":"2015","journal-title":"Lancet"},{"issue":"7650","key":"jrv230002r86","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"jrv230002r87","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2016.4287","article-title":"Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis.","volume":"74","author":"Cristea","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"jrv230002r88","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/00048674211046893","article-title":"Non-response to psychotherapy for borderline personality disorder: a systematic review.","volume":"56","author":"Woodbridge","year":"2022","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"jrv230002r89","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1176\/appi.ajp.2009.09081130","article-title":"Time to attainment of recovery from borderline personality disorder and stability of recovery: a 10-year prospective follow-up study.","volume":"167","author":"Zanarini","year":"2010","journal-title":"Am J Psychiatry"},{"key":"jrv230002r90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.psychres.2018.01.034","article-title":"Description and prediction of time-to-attainment of excellent recovery for borderline patients followed prospectively for 20 years.","volume":"262","author":"Zanarini","year":"2018","journal-title":"Psychiatry Res"},{"issue":"5","key":"jrv230002r91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/acps.2011.124.issue-5","article-title":"The 10-year course of PTSD in borderline patients and Axis II comparison subjects.","volume":"124","author":"Zanarini","year":"2011","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"jrv230002r92","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0447.2010.01543.x","article-title":"The 10-year course of psychosocial functioning among patients with borderline personality disorder and Axis II comparison subjects.","volume":"122","author":"Zanarini","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"jrv230002r93","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1037\/0021-843X.113.2.217","article-title":"The longitudinal relationship of personality traits and disorders.","volume":"113","author":"Warner","year":"2004","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"jrv230002r94","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1037\/a0016954","article-title":"The stability of personality traits in individuals with borderline personality disorder.","volume":"118","author":"Hopwood","year":"2009","journal-title":"J Abnorm Psychol"},{"issue":"2","key":"jrv230002r96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11920-019-0996-1","article-title":"Parenting in patients with borderline personality disorder, sequelae for the offspring and approaches to treatment and prevention.","volume":"21","author":"Florange","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"jrv230002r1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders.","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"jrv230002r2","volume-title":"Severe Personality Disorders: Psychotherapeutic Strategies","author":"Kernberg","year":"1984"},{"key":"jrv230002r18","volume-title":"International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"jrv230002r28","volume-title":"Transference-Focused Psychotherapy for Borderline Personality Disorder: A Clinical Guide","author":"Yeomans","year":"2015"},{"key":"jrv230002r29","doi-asserted-by":"crossref","DOI":"10.1093\/med:psych\/9780199680375.001.0001","volume-title":"Mentalization-Based Treatment for Personality Disorders: A Practical Guide","author":"Bateman","year":"2016"},{"key":"jrv230002r56","volume-title":"Principles of Psychoanalytic Psychotherapy: Manual for Supportive-Expressive Treatment","author":"Luborsky","year":"1984"},{"key":"jrv230002r65","volume-title":"User\u2019s Guide for the SCID-5-PD (Structured Clinical Interview for DSM-5 Personality Disorder)","author":"First","year":"2016"},{"key":"jrv230002r83","first-page":"387","volume-title":"Bergin and Garfield\u2019s Handbook of Psychotherapy and Behavior Change","author":"Barber","year":"2021","edition":"7th ed"},{"key":"jrv230002r84","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"jrv230002r85","volume-title":"Long-term Psychodynamic Psychotherapy","author":"Gabbard","year":"2004"},{"key":"jrv230002r95","first-page":"398","volume-title":"American Handbook of Psychiatry","author":"Schmideberg","year":"1959"},{"key":"jrv230002r61","unstructured":"National Institute for Health and Care Excellence. Borderline personality disorder: recognition and management\u2014clinical guideline. Published January 28, 2009. Accessed December 25, 2022. http:\/\/www.nice.org.uk\/guidance\/cg78"},{"key":"jrv230002r62","unstructured":"National Institute for Health and Care Excellence. Personality disorders: borderline and antisocial\u2014quality standard. Published June 11, 2015. Accessed December 25, 2022. http:\/\/nice.org.uk\/guidance\/qs88"},{"key":"jrv230002r81","unstructured":"National Institute for Health and Care Excellence. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Published 2004. Accessed December 26, 2022. https:\/\/www.nice.org\/uk\/guidance\/ta77"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2801843\/jama_leichsenring_2023_rv_230002_1676659334.01602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:02:03Z","timestamp":1677582123000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2801843"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":96,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,2,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.0589","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,28]]}}}